Nature Reviews Cancer

Papers
(The H4-Index of Nature Reviews Cancer is 77. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Linking pancreatic renewal and cancer initiation1581
Computing brain metastasis impact1125
Digging for treasures in the tumour interactome942
INVADEseq to study the intratumoural microbiota at host single-cell resolution578
An inhospitable site548
Combining spatial transcriptomics and AI to enhance brain tumour diagnosis517
Fructose takes a detour to feed cancer387
Combinatorial strategies to target RAS-driven cancers364
Emerging strategies to investigate the biology of early cancer364
Oncofetal reprogramming in tumour development and progression344
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment321
Artificial intelligence in cancer research, diagnosis and therapy313
Mapping the prostate cell family tree306
The evolution of cancer and ageing: a history of constraint302
How medical anthropology can contribute to cancer research302
Author Correction: Fighting rare cancers: lessons from fibrolamellar hepatocellular carcinoma289
Connie J. Eaves (1944–2024)276
The recruitment of metastasis-associated monocytes261
Antihistamines boost immunotherapy257
Fighting cancer with fat244
Tertiary lymphoid structures as hubs of antitumour immunity243
Reply to ‘Heterogeneity of TP53 mutations necessitates differentiation with p53-rescue therapies’242
The role of CRAF in cancer progression: from molecular mechanisms to precision therapies239
Translating premalignant biology to accelerate non-small-cell lung cancer interception224
Epithelial and stromal co-evolution and complicity in pancreatic cancer220
Context-dependent functions of pattern recognition receptors in cancer213
Targeting transcription cycles in cancer202
Beyond genetics: driving cancer with the tumour microenvironment behind the wheel191
3D chromatin architecture as a predictor of somatic mutations in cancer genomes190
No mutation, tumour initiation185
Impersonating neurons183
Under pressure179
Nanoreceptors take down mutant p53178
Gut microbes produce novel genotoxic metabolites173
Tumour EVPs disrupt liver function171
Dendritic cells rise and shine170
Persistence is key168
Removing barriers to address sex differences in anticancer drug toxicity168
Thelpers? More like Ttroublemakers166
AACR 2025161
Measuring HLA disruption using MHC Hammer158
Moonlighting functions of glucose metabolic enzymes and metabolites in cancer155
Defining a ‘cells to society’ research framework for appendiceal tumours151
Remodelling of the tumour microenvironment by the kallikrein-related peptidases145
Natural killer cells in antitumour adoptive cell immunotherapy143
3D bioprinted cancer models: from basic biology to drug development142
How chemokines organize the tumour microenvironment137
B-ring sterols to the rescue127
Points of entry for tumour-infiltrating lymphocytes127
Bone voyage: immune crosstalk sets sail123
Identifying spatial cellular structures with SPACE-GM122
In-depth organoid profiling of pancreatic cancer117
Visualizing intratumoural heterogeneity with EpicMIBI115
Environmental endocrine disruptors: rethinking the origins of early-onset ER+ breast cancer114
Un-Fair Skin: racial disparities in acral melanoma research112
The path to leptomeningeal metastasis108
Leveraging the replication stress response to optimize cancer therapy108
Linking cell mechanical memory and cancer metastasis107
Metabolic interplays between the tumour and the host shape the tumour macroenvironment107
Dynamics and specificities of T cells in cancer immunotherapy103
Regulatory T cells in the tumour microenvironment103
In situ decellularization of tissues to resolve the tumour-associated matrix102
Taming TAMs in brain metastases97
Encoding spatial tumour dynamics with Starfysh97
Race influences the tumour microbiome97
Understanding and addressing race disparities in childhood cancer outcomes97
Deciphering the cancer genome and epigenome96
Don’t blame the messenger: lessons learned for cancer mRNA vaccines during the COVID-19 pandemic95
The link between vitamin D and prostate cancer95
Polygenic scores in cancer94
Targeted protein degradation for cancer therapy92
Acetyl-CoA metabolism in cancer88
Cancer nanomedicine86
RNA splicing dysregulation and the hallmarks of cancer84
Z-nucleic acids give immunotherapy a boost82
Local CAR manufacturing80
Author Correction: Antibody-based proteomics: fast-tracking molecular diagnostics in oncology80
0.28248715400696